Schedule 13D ownership disclosure

TITAN PHARMACEUTICALS INC

Security class unavailable · CUSIP: 888314101

Event date: 2014-11-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.7500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-16-000612
Form type
SC 13D/A
Filer
ATP Life Science Ventures, L.P.
CIK
CIK 1593440
Filed
Feb 12, 2016
Reporting period
Nov 07, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub